Svelte Medical Systems Announces Final Patient Treated in the DIRECT Drug-Eluting Stent Study May 15, 2012 New Providence, NJ – Svelte® Medical Systems today announced completion of enrollment in the DIRECT (Direct Im - FACC - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2012-08-16 08:57:13 Immunosuppressants Macrolides Drug-eluting stent Medical equipment Stent Restenosis Sirolimus Cardiology Biosensors International Medicine Implants Interventional cardiology		Svelte Medical Systems Announces Final Patient Treated in the DIRECT Drug-Eluting Stent Study May 15, 2012 New Providence, NJ – Svelte® Medical Systems today announced completion of enrollment in the DIRECT (Direct Im Add to Reading List Source URL: www.apjohnventures.com Download Document from Source Website File Size: 33,70 KB Share Document on Facebook

	An Image-Based System for Change Detection on Tunnel Linings Simon Stent∗ , Riccardo Gherardi† , Bj¨orn Stenger† , Kenichi Soga∗ , Roberto Cipolla∗ ∗ † Department of Engineering, Toshiba Research Europe, DocID: 1uIUV - View Document
	Precise Deterministic Change Detection for Smooth Surfaces Simon Stent∗† † Riccardo Gherardi∗‡ DocID: 1tRF9 - View Document
	Appendix F: Definition of Terms ARC STENT THROMBOSIS Definite thrombosis: DocID: 1sVCu - View Document
	A UNSPSC® Success Story University Health Care System Augusta, Georgia “My first day on the job, my boss told me to just pay attention to coronary stents and spinal implants. I DocID: 1rt6x - View Document
	Patents & IP Sequences \| Clinical Trials \| Drug Pipelines Medical Devices: Insights from clinical trials, literature, and patents DPHT Spring Meeting 2016 – Orlando, Florida DocID: 1rkkV - View Document